Back to Search

MICHAEL BEDNARZ, MD

MD

Psychiatry Physician

NPI: 1184661407Individual

Specialties, Licenses & Credentials

Psychiatry PhysicianPrimary

Psychiatry & Neurology — Psychiatry

Code: 2084P0800X

036100780(IL)36100780(IL)

Research & Publications (11)

Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.
PMID 19489538·J Med Chem·2009
7-preclinical
Discovery of novel 1-arylmethyl pyrrolidin-2-yl ethanol amines as calcium-sensing receptor antagonists.
PMID 16216508·Bioorg Med Chem Lett·2005
8-other
Low-temperature dynamics of weakly localized Frenkel excitons in disordered linear chains.
PMID 15268548·J Chem Phys·2004
8-other
N-(cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent.
PMID 15027863·J Med Chem·2004
7-preclinical
A new strategy for the construction of the imidazo[1,5-a]quinoxalin-4-one ring system and its application to the efficient synthesis of BMS-238497, a novel and potent Lck inhibitor.
PMID 14750833·J Org Chem·2004
8-other
Temperature dependent fluorescence in disordered Frenkel chains: interplay of equilibration and local band-edge level structure.
PMID 14683333·Phys Rev Lett·2003
8-other
Rapid synthesis of triazine inhibitors of inosine monophosphate dehydrogenase.
PMID 12127522·Bioorg Med Chem Lett·2002
7-preclinical
A modified approach to 2-(N-aryl)-1,3-oxazoles: application to the synthesis of the IMPDH inhibitor BMS-337197 and analogues.
PMID 12049525·Org Lett·2002
8-other
Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-N-methyl-4- morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity.
PMID 12014950·J Med Chem·2002
7-preclinical
BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptor.
PMID 11714606·Bioorg Med Chem Lett·2001
7-preclinical
Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity.
PMID 11020273·J Med Chem·2000
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1601 WEST JACKSON STREET, SUITE 104
MACOMB, IL 61455

Location

Practice Location

1601 WEST JACKSON STREET, MACOMB, IL
(309) 575-3222

Quick Facts

NPI
1184661407
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
11

Are you this provider?

Claim Your Profile